Clinical Characteristics of Symptomatic Clostridium difficile Infection in Children: Conditions as Infection Risks and Whether Probiotics Is Effective
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: This study investigated the clinical presentations of symptomatic Clostridium difficile infection (CDI) in children. Methods: We reviewed the medical records of 43 children aged ＜20 years who showed either positive C. difficile culture or C. difficile toxin test results between June 2010 and April 2014. Results: Of the 43 patients (mean age 6.7 years), 22 were boys. Sixteen patients (37.2%) showed both positive C. difficile culture and toxin test results. Seventeen out of 43 children (39.5%) had preexisting gastrointestinal diseases, and 26 children had other medical conditions that were risk factors for CDI. Twenty-eight children had a history of antibiotic treatment for ＞3 days, and the most frequently prescribed antibiotic was amoxicillin-clavulanate (35.7%). Twenty-eight patients were diagnosed with CDI despite taking probiotic supplements, most commonly Lactobacillus acidophilus (53.6%). The most common symptom was diarrhea (72.1%) at the time CDI was diagnosed. C. difficile was eradicated in 11 patients (25.6%) after treatment with oral metronidazole for 10-14 days, and in the two patients (4.6%) who required two courses of oral metronidazole. Sixteen patients (37.2%) showed clinical improvement without any treatment. Conclusion: This study showed the various clinical characteristics of CDI in children and that preexisting clinical conditions favored the development of CDI. In addition, CDI was found to occur in a number of patients even after probiotic prophylaxis given in conjunction with antibiotic therapy.
Abstract
Purpose: This study investigated the clinical presentations of symptomatic Clostridium difficile infection (CDI) in children. Methods: We reviewed the medical records of 43 children aged ＜20 years who showed either positive C. difficile culture or C. difficile toxin test results between June 2010 and April 2014. Results: Of the 43 patients (mean age 6.7 years), 22 were boys. Sixteen patients (37.2%) showed both positive C. difficile culture and toxin test results. Seventeen out of 43 children (39.5%) had preexisting gastrointestinal diseases, and 26 children had other medical conditions that were risk factors for CDI. Twenty-eight children had a history of antibiotic treatment for ＞3 days, and the most frequently prescribed antibiotic was amoxicillin-clavulanate (35.7%). Twenty-eight patients were diagnosed with CDI despite taking probiotic supplements, most commonly Lactobacillus acidophilus (53.6%). The most common symptom was diarrhea (72.1%) at the time CDI was diagnosed. C. difficile was eradicated in 11 patients (25.6%) after treatment with oral metronidazole for 10-14 days, and in the two patients (4.6%) who required two courses of oral metronidazole. Sixteen patients (37.2%) showed clinical improvement without any treatment. Conclusion: This study showed the various clinical characteristics of CDI in children and that preexisting clinical conditions favored the development of CDI. In addition, CDI was found to occur in a number of patients even after probiotic prophylaxis given in conjunction with antibiotic therapy.
참고문헌 (28)
- Hall IC, "Intestinal flora in new-born infants:with a description of a new pathogenic anaerobe, bacillus difficilis", Am J Dis Child, 49, pp.390~402 (1935)
- Kristin E. Burke, "Clostridium difficile Infection: A Worldwide Disease", Gut and Liver, 8(1), pp.1~6 (2014), 거트앤리버 발행위원회
- Rousseau C, "Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains", Clin Infect Dis, 55, pp.1209~1215 (2012)
- Jangi S, "Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life", J Pediatr Gastroenterol Nutr, 51, pp.2~7 (2010)
- Kelly CP, "Clostridium difficile--more difficult than ever", N Engl J Med, 359, pp.1932~1940 (2008)
- Zilberberg MD, "Increase in adult Clostridium difficile-related hospitalizations and casefatality rate, United States, 2000-2005", Emerg Infect Dis, 14, pp.929~931 (2008)
- Pépin J, "Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity", CMAJ, 171, pp.466~472 (2004)
- Katikireddi V, "UK launches inquiry into Clostridium difficile outbreak", CMAJ, 173, pp.138~ (2005)
- Cohen MB, "Clostridium difficile infections: emerging epidemiology and new treatments", J Pediatr Gastroenterol Nutr, 48(2), pp.S63~S65 (2009)
- Zilberberg MD, "Clostridium difficile infections among hospitalized children, United States, 1997-2006", Emerg Infect Dis, 16, pp.604~609 (2010)
- Metchnikoff E, "The prolongation of life: optimistic studies", William Heinemann, pp.161~183 (1907)
- Lilly DM, "Probiotics: growth-promoting factors produced by microorganisms", Science, 147, pp.747~748 (1965)
- McFarland LV, "Pediatric Clostridium difficile: a phantom menace or clinical reality?", J Pediatr Gastroenterol Nutr, 31, pp.220~231 (2000)
- Bryant K, "Clostridium difficile infections in children", Pediatr Infect Dis J, 28, pp.145~146 (2009)
- Kim J, "Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006", Pediatrics, 122, pp.1266~1270 (2008)
- Wendt JM, "Clostridium difficile infection among children across diverse US geographic locations", Pediatrics, 133, pp.651~658 (2014)
- Pant C, "Clostridium difficile infection in children: a comprehensive review", Curr Med Res Opin, 29, pp.967~984 (2013)
- Sandora TJ, "Epidemiology and risk factors for Clostridium difficile infection in children", Pediatr Infect Dis J, 30, pp.580~584 (2011)
- Hourigan SK, "The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease", Dig Dis Sci, 59, pp.2222~2227 (2014)
- Warrack S, "Clostridium difficile in a children's hospital: assessment of environmental contamination", Am J Infect Control, 42, pp.802~804 (2014)
- Monaghan T, "Recent advances in Clostridium difficile-associated disease", Postgrad Med J, 85, pp.152~162 (2009)
- Khan R, "Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital", J Hosp Infect, 54, pp.104~108 (2003)
- 김병찬, "소아 Clostridium Difficile 장염과 관련된 항생제에 대한 연구", Pediatric Gastroenterology, Hepatology & Nutrition, 5(2), pp.143~149 (2002), 대한소아소화기영양학회
- McFarland LV, "Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease", Am J Gastroenterol, 101, pp.812~822 (2006)
- Hell M, "Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic", Benef Microbes, 4, pp.39~51 (2013)
- Goldenberg JZ, "Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children", Cochrane Database Syst Rev, 5, pp.CD006095~ (2013)
- Ooi CY, "Saccharomyces boulardii in a child with recurrent Clostridium difficile", Pediatr Int, 51, pp.156~158 (2009)
- Johnston BC, "Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis", Ann Intern Med, 157, pp.878~888 (2012)